India's Venus Remedies rises most in 1 month on nod to sell chemo drugs

Venus Remedies

21/12/2023 08:33

** Shares of pharma company Venus Remedies  VENR.NS  rise as much as 8.6% to
408.7 rupees, their steepest climb in a month
    ** VENR gets marketing authorisations for chemotherapy medications
Docetaxel In Israel And Cytarabine in Colombia 
    ** Stock last up 6.3%, bumping YTD gains to 121%

 (Reporting by Anisha Ajith)
 ((anisha.ajith@thomsonreuters.com;))